Aclaris Therapeutics Statistics
Total Valuation
ACRS has a market cap or net worth of $94.07 million. The enterprise value is -$34.10 million.
| Market Cap | 94.07M |
| Enterprise Value | -34.10M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, before market open.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACRS has 71.26 million shares outstanding. The number of shares has increased by 6.28% in one year.
| Shares Outstanding | 71.26M |
| Shares Change (YoY) | +6.28% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 2.55% |
| Owned by Institutions (%) | 78.41% |
| Float | 55.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.02 |
| Forward PS | 11.51 |
| PB Ratio | 0.66 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.74, with zero debt.
| Current Ratio | 6.74 |
| Quick Ratio | 6.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.60% and return on invested capital (ROIC) is -77.22%.
| Return on Equity (ROE) | -48.60% |
| Return on Assets (ROA) | -37.40% |
| Return on Capital (ROIC) | -77.22% |
| Revenue Per Employee | $341,967 |
| Profits Per Employee | -$849,033 |
| Employee Count | 91 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -367,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.34% in the last 52 weeks. The beta is 0.28, so ACRS's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -87.34% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.75 |
| Relative Strength Index (RSI) | 61.97 |
| Average Volume (20 Days) | 1,471,573 |
Short Selling Information
The latest short interest is 3.94 million, so 5.53% of the outstanding shares have been sold short.
| Short Interest | 3.94M |
| Short Previous Month | 4.46M |
| Short % of Shares Out | 5.53% |
| Short % of Float | 7.04% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, ACRS had revenue of $31.12 million and -$77.26 million in losses. Loss per share was -$1.09.
| Revenue | 31.12M |
| Gross Profit | 13.07M |
| Operating Income | -109.67M |
| Pretax Income | -77.63M |
| Net Income | -77.26M |
| EBITDA | -76.72M |
| EBIT | -77.63M |
| Loss Per Share | -$1.09 |
Balance Sheet
The company has $128.17 million in cash and no debt, giving a net cash position of $128.17 million or $1.80 per share.
| Cash & Cash Equivalents | 128.17M |
| Total Debt | n/a |
| Net Cash | 128.17M |
| Net Cash Per Share | $1.80 |
| Equity (Book Value) | 142.01M |
| Book Value Per Share | 1.99 |
| Working Capital | 115.26M |
Cash Flow
In the last 12 months, operating cash flow was -$72.79 million and capital expenditures -$891,000, giving a free cash flow of -$73.68 million.
| Operating Cash Flow | -72.79M |
| Capital Expenditures | -891,000 |
| Free Cash Flow | -73.68M |
| FCF Per Share | -$1.04 |
Margins
Gross margin is 41.99%, with operating and profit margins of -352.42% and -248.28%.
| Gross Margin | 41.99% |
| Operating Margin | -352.42% |
| Pretax Margin | -249.46% |
| Profit Margin | -248.28% |
| EBITDA Margin | -246.54% |
| EBIT Margin | -249.46% |
| FCF Margin | -236.76% |
Dividends & Yields
ACRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.28% |
| Shareholder Yield | -6.28% |
| Earnings Yield | -82.13% |
| FCF Yield | -78.32% |
Analyst Forecast
The average price target for ACRS is $11.50, which is 771.21% higher than the current price. The consensus rating is "Hold".
| Price Target | $11.50 |
| Price Target Difference | 771.21% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 0.87% |
| EPS Growth Forecast (5Y) | -34.51% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACRS has an Altman Z-Score of -5.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.07 |
| Piotroski F-Score | 2 |